Chen Huaigang, Wang Hong, Li Bin, Hong Lang, Kuang Maobin, Yang Liu
Medical College of Nanchang University, Nanchang, Jiangxi Province, China.
Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi Province, China.
Front Med (Lausanne). 2023 Mar 22;10:1148581. doi: 10.3389/fmed.2023.1148581. eCollection 2023.
Therapy for patients with ST-elevation myocardial infarction (STEMI) has been a controversial topic since the introduction of thrombolytic agents in the 1980s. The use of morphine, fentanyl and lidocaine has increased substantially during this period. However, there is still limited evidence on their advantages and limitations. In this review, the clinical application, as well as future considerations of morphine, fentanyl and lidocaine in patients with ST segment elevation myocardial infarction were discussed.
自20世纪80年代引入溶栓药物以来,ST段抬高型心肌梗死(STEMI)患者的治疗一直是一个有争议的话题。在此期间,吗啡、芬太尼和利多卡因的使用大幅增加。然而,关于它们的优缺点仍证据有限。在本综述中,讨论了吗啡、芬太尼和利多卡因在ST段抬高型心肌梗死患者中的临床应用以及未来的考量。